002422 科伦药业
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额249,6112,642,0684,492,8625,337,0693,126,958
投资活动产生之现金流量净额(794,355)(1,288,261)(1,819,368)(3,370,325)(857,096)
筹资活动产生之现金流量净额1,046,309684,029(3,304,276)(2,058,766)(407,261)
汇率变动对现金及现金等价物的影响(807)(45,927)(12,780)5,1947,934
现金及现金等价物净增加/(减少)500,7591,991,910(643,562)(86,828)1,870,535
期初现金及现金等价物余额5,936,6723,944,7624,588,3244,675,1522,804,617
期末现金及现金等价物余额6,437,4305,936,6723,944,7624,588,3244,675,152